Why Delay Intervention in STEMI?  by Mewton, Nathan et al.
1
c
f
l
s
r
A
T
c
E
w
k
i
r
M
g
a
v
p
c
u
d
a
b
i
a
0
l
r
s
m
p
r
t
s
t
r
s
8
c
p
c
d
s
s
e
c
o
e
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 8 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C .L E T T E R S T O T H E E D I T O R
Pocket-Sized Echo for Evaluation
of Mitral and Tricuspid
Regurgitation
Advances in electronic miniaturization and digital techniques
have resulted in the advent of portable transthoracic echocar-
diography (pTTE) imaging devices in the area of echocardiog-
raphy. A pocket-sized pTTE imaging device that has color
Doppler imaging capability has been recently introduced into
clinical practice. This study aimed to examine the feasibility
and accuracy of the pocket-sized pTTE in the assessment of
the severity of mitral regurgitation (MR) and tricuspid regur-
gitation (TR).
One hundred and eighty-six consecutive patients (ages 66 
9 years; 107 male) underwent standard transthoracic echo-
ardiography (sTTE) and pTTE. Initially, pTTE was per-
ormed by a well-trained sonographer for 121 patients. For the
ater 65 patients, pTTE was examined by a less experienced
onographer who had 6 months of experience in echocardiog-
aphy, with the number of TTE examinations compatible with
merican Society of Echocardiography training level 1 (1).
hese sonographers were blinded to sTTE results and all
linical information.
This study was approved by the ethics committees of Osaka
kisaikai Hospital and Okayama University. Pocket-sized pTTE
as performed using the Vscan (GE Medical Systems, Milwau-
ee,Wisconsin). The apical 4-chamber view by the color Doppler
mages was obtained with sTTE and pTTE, respectively. The
atio of regurgitant jet area to atrial area was then calculated for
R (%MR) and TR (%TR). The severity of regurgitation was
raded as mild if it occupied 20%, moderate if between 20%
nd 34%, and severe if 34% in TTE examination.
Linear regression analysis was used for the correlation of
ariables of interest. Differences were considered significant at
 0.05. Differences between sTTE and pTTE results were also
ompared with the mean value obtained by sTTE and pTTE
sing the Bland-Altman method, with the limits of agreement
efined as  2 SD of the difference between the 2 methods.
Echocardiographic measurements were completed for sTTE
nd pTTE in all patients (feasibility 100%). In the examination
y the well-trained sonographer, there were excellent correlations
n MR jet area, left atrial area, %MR, TR jet area, right atrial
rea, and %TR between sTTE and pTTE (r 0.89 to 0.96, p
.001). Also, there were small systematic differences with close
imits of agreement between sTTE and pTTE measurements,
espectively: 0.2 cm2 and 1.5 cm2 for MR jet area; 0.4 cm2
and 4.6 cm2 for left atrial area;0.5 cm2 and 5.6 cm2 for %MR;
0.2 cm2 and 2.3 cm2 for TR jet area; 0.0 cm2 and 4.2 cm2 for
right atrial area; and 1.2 cm2 and 8.9 cm2 for %TR. The
ensitivity and specificity of pTTE for detecting more thanoderate MR were both 96%. The sensitivity and specificity of
TTE for detecting more than moderate TR were 94% and 96%,
espectively. In patients with more than moderate regurgitation,
he evaluation of the etiology of MR and TR by pTTE was the
ame as for those with sTTE.
In the examination with the less experienced sonographer,
he correlations between sTTE and pTTE were slightly
educed (r  0.85 to 0.94, p  0.001). The sensitivity and
pecificity for detecting more than moderate MR and TR were
5% and 92%, and 95% and 80%, respectively.
Pocket-sized portable devices are much lighter than the
onventional echocardiographic imaging devices, enabling the
hysician to carry and use them anywhere, such as in outpatient
linics, ward rounds, and emergency settings, as well as for family
octor visits. Some drawbacks to pocket-sized devices are the
mall display and limited control features, and their accuracy
hould be evaluated. We demonstrated that, considering the
xperience in echocardiography (1), the pocket-sized pTTE with
olor Doppler feature was feasible and accurate in the assessment
f the severity and etiology of MR and TR, and that should
nhance the widespread use of pTTE in clinical practice.
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Why Delay Intervention in STEMI?
We read with interest the report by Yamashita et al. (1)
regarding the noninvasive assessment of coronary “perfusion”
by contrast-enhanced coronary multidetector computed to-
mography (MDCT) during the acute phase in patients with
ST-segment elevation myocardial infarction (STEMI) before
therapeutic reperfusion.
This pioneering study demonstrates that contrast-enhanced
MDCT can be performed within 20 min in patients with
STEMI at an experienced institution to evaluate coronary
perfusion, with good levels of accuracy. In their study, Ya-
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Letters to the Editor922mashita et al. (1) showed that pre-reperfusion contrast-enhanced
MDCT is feasible, with a door–to–invasive coronary angiography
time of about 78 min. The door-to-balloon time is not provided by
the investigators in the report but should therefore have been
approximately 90 min, the “target” time set by the most recent
guidelines (2).
As such, this study seems to contradict the guideline that timely
reperfusion be performed in patients with STEMI (2). Yamashita
et al. (1), as well as the editors of iJACC, have decided to open the
ebate over the “time is muscle” paradigm. It is true that it would
e very difficult to show what amount of myocardium would be
rreversibly damaged in the final 20 min of a 4-h to 5-h ischemic
eriod, accounting for the many factors that influence final infarct size
3). In our opinion, it would be of interest to discuss the position of the
nvestigators and editors on this specific question, which is not
iscussed in this report. This question is a sensitive one in the
ardiology community, in which the opinion that a delay in reperfusion
s in conflict with optimal patient care, is shared by many.
The study further opens the door to the important potential of
ardiac MDCT in the acute phase of infarction. Beyond its capacity
o assess coronary perfusion before angioplasty, cardiac MDCT
ould be a very powerful tool to assess the myocardial area at risk.
he accurate assessment of this major determinant of infarct size is
ssential to all therapeutic studies investigating new reperfusion
herapies to increase myocardial salvage and improve patient out-
omes (4). This question is important, because the other clinically
vailable imaging methods to assess the myocardial area at risk
single photon-emission computed tomography, T2-weighted car-
iac magnetic resonance) are not considered definitive standards
nd have well-known limitations. With respect to this issue, it
ould be interesting to know whether Yamashita et al. (1) also
ssessed myocardial perfusion at the tissue level in this cohort of
atients.
Cardiac contrast-enhanced MDCT offers the potential of a
idely available and relatively safe noninvasive imaging method to
ssess STEMI. The current and future applications of the present
ethod must be framed so as to control the absence of adverse
ffects in study patients but offer promising perspectives to better
nderstand and explore STEMI.
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for their valuable comments and suggestions regarding our study
(1,2). They ask whether computed tomography (CT) coronary
angiography performed before emergent percutaneous coronary
intervention (PCI) in patients with ST-segment elevation myo-
cardial infarction (STEMI) inappropriately delayed PCI as per
accepted guidelines (3,4). It is essential to be fully aware of the
specific ethical considerations when reviewing this study. For
example, STEMI patients included in this study were limited to
those with Killip classification 1. Further, CT angiography was
performed in a rapid fashion, at a mean time interval to PCI of
20 min, and CT angiography was completed within the time
required to prepare the catheterization laboratory. Conse-
quently, we believe that the time required to complete the CT
angiography did not appreciably affect patient care. Although we
demonstrated that CT angiography enabled the characterization
of coronary reperfusion during the acute phase in STEMI
patients, we acknowledge that the clinical application of CT
angiography before PCI should be conducted with caution in
patients with STEMI.
As suggested by Mewton et al., CT can be a very powerful tool
to assess the myocardial area at risk in the setting of STEMI. We
regret that we did not assess myocardial perfusion at the tissue level
using CT in our study. Recently, Rodriguez-Granillo et al. (5)
demonstrated that early detection of myocardial viability immedi-
ately after primary PCI, as characterized by delayed enhancement
on multidetector CT, is related to the extent of myocardial damage.
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